Healius Could Return A$300 Million From Lumus Sale -- Market Talk

Dow Jones
2024-11-20

2251 GMT - Healius could return some A$300 million to its shareholders from selling its imaging business Lumus, reckons Citi. Healius in September said it would sell Lumus to Affinity Equity Partners for A$965 million, but didn't specify how much of the proceeds would be returned to shareholders. Analyst Mathieu Chevrier thinks it could involve Healius declaring a special dividend of A$0.40/share. "We upgrade to Neutral on recent share price decline, sale of Lumus which will make Healius debt-free, and a pathology cost base now likely more reflective of true business-as-usual costs," Citi says. (david.winning@wsj.com; @dwinningWSJ)

 

(END) Dow Jones Newswires

November 19, 2024 17:52 ET (22:52 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10